Thompson Davis & Co’s Adtran ADTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,865
Closed -$149K 170
2026
Q1
$149K Buy
+11,865
New +$120K 0.1% 121
2025
Q2
Sell
-18,675
Closed -$163K 140
2025
Q1
$163K Buy
+18,675
New +$188K 0.13% 101
2017
Q4
Sell
-6,525
Closed -$157K 667
2017
Q3
$157K Buy
+6,525
New +$144K 0.28% 84
2017
Q1
Sell
-2,000
Closed -$45K 1141
2016
Q4
$45K Buy
+2,000
New +$40.4K 0.07% 255
2016
Q2
Sell
-250
Closed -$5K 1046
2016
Q1
$5K Buy
+250
New +$4.62K 0.01% 771

Other funds holding ADTN

Thompson Davis & Co's ADTN Position: Q2 2026 in Review

Thompson Davis & Co sold out of Adtran (ADTN) in Q2 2026, closing a stake of 11,865 shares — an estimated $149K sold.

Thompson Davis & Co first reported a position in ADTN in Q1 2016 and held it in 5 quarters. The position peaked at $163K in Q1 2025. 249 funds tracked by Wall St. Rank hold ADTN as of Q2 2026.

  • Thompson Davis & Co reported no remaining Adtran position as of Q2 2026 after selling out during the quarter.
  • Thompson Davis & Co sold 11,865 Adtran shares in Q2 2026, an estimated $149K.
  • Thompson Davis & Co first reported a position in Adtran in Q1 2016 and held it in 5 quarters.
  • Thompson Davis & Co's Adtran position peaked at $163K in Q1 2025.
  • 249 funds tracked by Wall St. Rank held Adtran as of Q2 2026.

Based on Thompson Davis & Co's 13F filing for Q2 2026, filed 29 Jul 2026.